Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica (NMO)”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00904826
What this trial is testing

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Who this might be right for
Neuromyelitis OpticaDevic's Disease
Mayo Clinic 14
Early research (Phase 1)Study completedNCT02276963
What this trial is testing

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 6
Not applicableUnknownNCT04822623
What this trial is testing

Imaging Evaluation of Central Nervous Autoimmune Diseases

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder
Qilu Hospital of Shandong University 300
Large-scale testing (Phase 3)Study completedNCT02003144
What this trial is testing

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 119
Not applicableLooking for participantsNCT04106830
What this trial is testing

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

Who this might be right for
NMO Spectrum DisorderMRIMultiple Sclerosis+1 more
Beijing Tiantan Hospital 1,000
Not applicableStudy completedNCT04355611
What this trial is testing

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderCOVID-19
Assistance Publique - Hôpitaux de Paris 2,465
Not applicableLooking for participantsNCT06885957
What this trial is testing

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

Who this might be right for
NMO Spectrum Disorder
Tongji Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT06673394
What this trial is testing

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Not applicableStudy completedNCT05155644
What this trial is testing

Safety of Therapeutic Step-down in Neuromyelitis Optica

Who this might be right for
Neuromyelitis Optica
University Hospital, Strasbourg, France 947
Not applicableUnknownNCT03514030
What this trial is testing

Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China

Who this might be right for
NMO Spectrum Disorder;Registry Study
Beijing Tongren Hospital 400
Large-scale testing (Phase 3)Study completedNCT04201262
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 58
Post-approval studies (Phase 4)Study completedNCT05896605
What this trial is testing

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMO Spectrum DisorderAzathioprine Adverse Reaction
First Affiliated Hospital of Guangxi Medical University 63
Testing effectiveness (Phase 2)WithdrawnNCT05974293
What this trial is testing

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum DisorderSpasticity, Muscle
Michael, Levy M.D.,Ph.D.
Testing effectiveness (Phase 2)Ended earlyNCT01339455
What this trial is testing

Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica

Who this might be right for
Neuromyelitis Optica
University of Calgary 3
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Not applicableUnknownNCT04601142
What this trial is testing

Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism

Who this might be right for
Glucocorticoid ResistanceGeneNeuromyelitis Optica
Beijing Tongren Hospital 350
Large-scale testing (Phase 3)Ended earlyNCT04155424
What this trial is testing

The Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 5
Next Page